YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,GeoLocation,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.5,78.5,,,76,80.8,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.8,75.8,,,73.6,77.9,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.8,75.8,,,73.5,77.9,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,70,70,,,67.8,72.1,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.4,68.4,,,64.6,72.1,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,68.8,68.8,,,65.1,72.4,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,66.1,66.1,,,62,69.9,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,66.3,66.3,,,62.3,70.1,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.7,76.7,,,64.6,85.5,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.6,76.6,,,65.7,84.9,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.4,83.4,,,75.2,89.2,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.9,82.9,,,74.2,89,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.5,78.5,,,67.7,86.4,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77,77,,,65.1,85.7,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77,77,,,74.8,79,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.5,76.5,,,74.3,78.6,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.3,76.3,,,73.8,78.6,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.9,75.9,,,73.3,78.2,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.9,81.9,,,77.8,85.4,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.8,80.8,,,76.5,84.5,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.1,68.1,,,64.8,71.3,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,67.1,67.1,,,63.6,70.3,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.2,68.2,,,64.6,71.6,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,66.8,66.8,,,63,70.4,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.1,74.1,,,64.5,81.8,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.1,75.1,,,67.2,81.7,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.3,76.3,,,74.3,78.1,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.8,75.8,,,73.7,77.8,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.3,76.3,,,74.3,78.1,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.7,75.7,,,73.5,77.7,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.2,85.2,,,73.1,92.5,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.9,84.9,,,74.5,91.5,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.7,74.7,,,67.7,80.6,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74.6,74.6,,,67.7,80.4,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.5,76.5,,,65.1,85,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.1,77.1,,,66,85.4,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.8,82.8,,,80.5,85,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.7,82.7,,,80.2,84.8,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.1,81.1,,,78,83.7,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.6,80.6,,,77.4,83.4,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,91.4,91.4,,,79.9,96.6,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,92.1,92.1,,,82.6,96.6,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.1,81.1,,,75.2,85.9,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.9,80.9,,,74.6,85.9,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,89.4,89.4,,,82.6,93.7,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,88.7,88.7,,,80.8,93.7,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.1,74.1,,,72.2,75.8,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.9,73.9,,,72.1,75.7,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.1,74.1,,,72.1,76,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74,74,,,72,75.9,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.4,85.4,,,73.2,92.6,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.2,85.2,,,73.2,92.4,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.9,74.9,,,68.7,80.3,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.7,73.7,,,67.3,79.1,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.4,72.4,,,55,84.9,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,79.5,79.5,,,68.9,87.1,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,56.9,56.9,,,40.4,72,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,60.9,60.9,,,43.9,75.6,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.5,83.5,,,81.4,85.5,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.7,83.7,,,81.6,85.6,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.8,83.8,,,81.4,85.9,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.9,83.9,,,81.5,86,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,88.6,88.6,,,82.1,92.9,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.8,87.8,,,81.2,92.3,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.5,78.5,,,68.4,86.1,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.8,78.8,,,69.5,85.8,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.2,81.2,,,78.1,83.9,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.1,81.1,,,78,83.9,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.9,78.9,,,74.1,83.1,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,79.5,79.5,,,74.7,83.6,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,84,84,,,79.7,87.6,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.9,83.9,,,79.4,87.6,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.5,85.5,,,83,87.7,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.3,85.3,,,82.8,87.6,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,84.5,84.5,,,81.5,87.1,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.4,84.4,,,81.3,87.1,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,88.5,88.5,,,81.5,93,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,88.6,88.6,,,82.1,93,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,86.8,86.8,,,82.3,90.2,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.3,76.3,,,64.5,85.1,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.4,77.4,,,67.4,85.1,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.5,77.5,,,75.5,79.5,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.2,77.2,,,75.1,79.2,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.1,76.1,,,74.1,77.9,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.3,75.3,,,73.1,77.3,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.8,85.8,,,79.6,90.3,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,86.3,86.3,,,81.1,90.2,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.5,77.5,,,68.9,84.2,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.9,76.9,,,68.8,83.5,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,65.3,65.3,,,50.2,77.8,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,65.6,65.6,,,53.4,76,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,70.6,70.6,,,49.8,85.3,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,67.6,67.6,,,53.5,79.1,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.4,78.4,,,76.3,80.3,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.8,77.8,,,75.6,79.8,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.3,78.3,,,76.1,80.4,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.1,77.1,,,74.6,79.4,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,87.8,87.8,,,81.7,92.1,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,88.7,88.7,,,83.3,92.5,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.4,72.4,,,64.6,79.1,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.4,73.4,,,65.8,79.7,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.8,80.8,,,78.8,82.8,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.9,80.9,,,78.6,82.9,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81,81,,,78.8,83.1,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.4,80.4,,,77.7,82.9,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.5,80.5,,,77.8,83,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.9,83.9,,,79.5,87.6,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.1,84.1,,,79.8,87.7,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.9,79.9,,,77.5,82.1,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80,80,,,77.5,82.2,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.1,78.1,,,75.2,80.8,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.7,77.7,,,74.7,80.6,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.5,80.5,,,78.4,82.5,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.1,87.1,,,82.7,90.6,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.6,72.6,,,65.6,78.7,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72.2,72.2,,,65.3,78.1,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,70.7,70.7,,,62,78.1,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,70.7,70.7,,,62.2,77.9,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85,85,,,82.6,87.1,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.1,85.1,,,82.7,87.3,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82,82,,,77.8,85.5,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.1,82.1,,,77.4,86,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.4,82.4,,,71.9,89.6,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.5,81.5,,,71.4,88.6,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,87.6,87.6,,,83.7,90.8,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.7,87.7,,,83.6,90.9,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.2,83.2,,,77.5,87.7,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83,83,,,77.5,87.5,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.5,83.5,,,80.9,85.8,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.4,83.4,,,80.7,85.8,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.3,80.3,,,76.4,83.7,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.3,81.3,,,77.5,84.6,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.5,79.5,,,67.9,87.7,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.3,80.3,,,69.7,87.8,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,84.6,84.6,,,80,88.4,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.2,84.2,,,79.4,88.1,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.6,85.6,,,81,89.2,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.7,85.7,,,81,89.4,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.1,81.1,,,79,83,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.8,80.8,,,78.7,82.8,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.6,68.6,,,65.4,71.7,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,68.4,68.4,,,65.1,71.6,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,69.4,69.4,,,66.1,72.5,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.2,69.2,,,65.7,72.4,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.1,78.1,,,75.3,80.7,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.2,78.2,,,75.4,80.7,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.2,77.2,,,74.1,80,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.2,77.2,,,74.1,80.1,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,84.5,84.5,,,76.7,90.1,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.4,84.4,,,76.6,89.9,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78,78,,,63.6,87.8,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.9,80.9,,,68.6,89.1,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.5,72.5,,,70.5,74.3,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72.4,72.4,,,70.4,74.3,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,71.9,71.9,,,69.9,73.9,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,71.9,71.9,,,69.8,73.9,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.6,80.6,,,72.6,86.8,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.3,81.3,,,73.2,87.3,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.4,76.4,,,74.7,77.9,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.1,76.1,,,74.4,77.7,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.9,76.9,,,75.2,78.5,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.5,76.5,,,74.7,78.2,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.6,78.6,,,69.5,85.6,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.3,78.3,,,69.5,85,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68,68,,,55.6,78.3,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.1,69.1,,,58,78.4,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,71.2,71.2,,,56.3,82.6,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,67.8,67.8,,,51.2,80.9,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,59.7,59.7,,,44.1,73.5,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,63.5,63.5,,,48.8,76,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.6,79.6,,,77.5,81.6,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,79.2,79.2,,,77,81.2,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.6,79.6,,,77.4,81.7,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,79.1,79.1,,,76.7,81.2,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,84.8,84.8,,,76.3,90.7,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.4,87.4,,,81.2,91.7,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,60.9,60.9,,,49,71.6,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.5,79.5,,,77.4,81.5,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,79.2,79.2,,,77,81.2,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.3,78.3,,,75.6,80.8,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.8,77.8,,,75,80.4,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.1,81.1,,,77,84.5,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.2,81.2,,,77.1,84.6,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,88,88,,,86.4,89.4,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.9,87.9,,,86.3,89.4,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,87.9,87.9,,,86.1,89.4,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.7,87.7,,,85.9,89.3,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,86.2,86.2,,,76.9,92.2,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,86.8,86.8,,,78.5,92.2,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,88,88,,,79.8,93.2,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.3,87.3,,,79.3,92.5,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,94.9,94.9,,,89.2,97.7,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,94.7,94.7,,,88.8,97.6,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,88.4,88.4,,,69.7,96.2,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,88.6,88.6,,,74.2,95.4,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.6,83.6,,,81.7,85.3,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.5,83.5,,,81.6,85.2,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.4,81.4,,,79.3,83.4,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.3,81.3,,,79.1,83.3,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,89,89,,,84.9,92,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,88.9,88.9,,,85,91.9,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,90.6,90.6,,,78.4,96.2,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,90.5,90.5,,,78.6,96.1,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.1,77.1,,,62.4,87.3,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.7,75.7,,,63.3,84.9,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.9,82.9,,,63.7,93,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.1,82.1,,,63.7,92.3,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83,83,,,81.2,84.7,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.9,82.9,,,81.1,84.6,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.1,83.1,,,81.3,84.8,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83,83,,,81.1,84.7,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.9,81.9,,,79.9,83.7,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.9,81.9,,,79.9,83.7,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.7,81.7,,,79.6,83.6,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.8,81.8,,,79.7,83.7,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,84.8,84.8,,,78.2,89.6,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.5,84.5,,,77.8,89.4,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.6,81.6,,,80.2,83,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.5,81.5,,,80,82.9,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.7,81.7,,,80.2,83.1,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.6,81.6,,,80.1,83,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,87.4,87.4,,,76.7,93.6,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.8,87.8,,,78.1,93.6,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,69.3,69.3,,,54.2,81.1,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74.9,74.9,,,62.4,84.3,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.1,78.1,,,61.8,88.7,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.7,75.7,,,61.1,86.1,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.6,72.6,,,69.8,75.3,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72.6,72.6,,,69.7,75.3,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.1,72.1,,,69.1,74.9,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72,72,,,68.9,74.9,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.9,76.9,,,66.6,84.8,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.4,77.4,,,67.8,84.8,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,69.6,69.6,,,66.2,72.8,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.5,69.5,,,66.1,72.8,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.6,68.6,,,64.3,72.7,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,68.7,68.7,,,64.2,72.9,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74,74,,,68.2,79,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.9,73.9,,,68.4,78.7,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.9,72.9,,,70.1,75.5,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72,72,,,69,74.7,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,73.3,73.3,,,70.4,76,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72.3,72.3,,,69.1,75.2,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.9,68.9,,,56.8,78.8,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,70.1,70.1,,,59.4,78.9,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.7,80.7,,,78.6,82.7,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.9,80.9,,,78.7,82.9,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81,81,,,78.5,83.3,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.2,81.2,,,78.6,83.6,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.3,81.3,,,76.3,85.4,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.2,81.2,,,76.2,85.4,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,70.1,70.1,,,56.6,80.8,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.4,74.4,,,58.7,85.6,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76,76,,,73.3,78.5,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.6,75.6,,,72.9,78.2,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.6,76.6,,,73.9,79.1,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.2,76.2,,,73.4,78.8,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,67.1,67.1,,,48.5,81.5,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72,72,,,56.3,83.7,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.9,75.9,,,74.3,77.4,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.1,76.1,,,74.5,77.6,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.3,76.3,,,74.6,77.8,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.5,76.5,,,74.8,78,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.7,82.7,,,68.2,91.4,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.2,83.2,,,71.4,90.8,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,66.5,66.5,,,54.4,76.8,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,65.7,65.7,,,53.6,76.1,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,61.2,61.2,,,43.4,76.4,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,63.3,63.3,,,51.7,73.6,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.1,83.1,,,80.8,85.1,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.5,83.5,,,81.2,85.5,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.1,83.1,,,80.8,85.2,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.4,83.4,,,81.1,85.5,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.3,78.3,,,75.9,80.4,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.2,78.2,,,75.9,80.4,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77,77,,,74.6,79.3,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.7,76.7,,,74.3,79,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.5,82.5,,,75,88.1,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.1,82.1,,,75,87.5,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.9,78.9,,,69.1,86.2,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.6,80.6,,,72.9,86.5,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.8,81.8,,,64.7,91.7,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.4,83.4,,,69.3,91.8,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72,72,,,69.5,74.4,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,71.6,71.6,,,69,74.1,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,70.8,70.8,,,67.5,74,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,70.2,70.2,,,66.7,73.5,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.2,74.2,,,69.6,78.4,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.6,73.6,,,68.8,77.8,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,73,73,,,62,81.8,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72.7,72.7,,,62.8,80.8,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,72.2,72.2,,,67.9,76.2,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,71.6,71.6,,,67.1,75.7,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,71.5,71.5,,,66.9,75.7,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,70,70,,,65.1,74.5,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75,75,,,60.3,85.6,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.4,73.4,,,61.2,82.8,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.5,78.5,,,75.9,80.8,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.1,78.1,,,75.3,80.8,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.4,78.4,,,75.5,81,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82,82,,,75,87.4,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.3,82.3,,,75.7,87.3,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,86,86,,,79.3,90.8,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.3,85.3,,,78.2,90.4,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,67.9,67.9,,,50.7,81.2,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,58.6,58.6,,,45,71,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.3,74.3,,,71.9,76.6,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74,74,,,71.6,76.4,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.9,83.9,,,75.3,89.9,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.2,85.2,,,78.6,90,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.7,69.7,,,67.4,71.9,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,70.3,70.3,,,67.8,72.6,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.8,69.8,,,67.2,72.2,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,71.1,71.1,,,61,79.5,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,68.6,68.6,,,57.7,77.8,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,57.5,57.5,,,42,71.6,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,53.5,53.5,,,39.5,67,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.5,68.5,,,59.4,76.4,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,67.7,67.7,,,58.8,75.5,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,74.1,74.1,,,63.9,82.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74.6,74.6,,,65.4,82,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.9,76.9,,,74.1,79.5,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.5,76.5,,,73.5,79.3,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.2,76.2,,,73.2,78.9,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.7,75.7,,,72.5,78.7,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78,78,,,66.2,86.5,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.5,76.5,,,64.1,85.6,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.3,77.3,,,75.3,79.1,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.1,77.1,,,75,79,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77,77,,,74.9,79,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.8,76.8,,,74.6,78.8,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.2,81.2,,,72.7,87.5,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.3,81.3,,,73.4,87.3,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.4,82.4,,,79.9,84.6,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.2,82.2,,,79.7,84.5,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.5,82.5,,,80,84.7,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,82.2,82.2,,,79.7,84.5,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.1,85.1,,,83,87,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.9,84.9,,,82.7,86.9,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,85.4,85.4,,,83.2,87.3,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,85.2,85.2,,,82.9,87.2,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.5,76.5,,,50.9,91.1,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.1,73.1,,,51.1,87.6,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.3,83.3,,,72.6,90.3,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.6,81.6,,,70,89.4,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.7,76.7,,,74.8,78.6,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.2,76.2,,,74.2,78.2,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.2,75.2,,,72.8,77.4,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74.4,74.4,,,71.9,76.8,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.6,81.6,,,77.7,84.9,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.4,81.4,,,77.3,84.9,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.2,80.2,,,76.9,83.1,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.7,80.7,,,77.6,83.5,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.3,80.3,,,76.9,83.3,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.9,80.9,,,77.7,83.8,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79,79,,,63.4,89.1,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.7,78.7,,,64.5,88.3,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.8,76.8,,,73.9,79.4,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.9,76.9,,,73.9,79.5,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.2,76.2,,,73.1,79.1,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.2,76.2,,,72.9,79.1,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,83.2,83.2,,,75.7,88.8,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,84.4,84.4,,,77.8,89.4,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.8,78.8,,,76,81.3,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.8,78.8,,,75.9,81.3,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.9,78.9,,,76,81.6,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.9,78.9,,,75.9,81.7,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.3,78.3,,,68.4,85.7,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.2,78.2,,,68.9,85.3,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,57.7,57.7,,,33.6,78.5,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,76.7,76.7,,,74.4,78.9,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.9,76.9,,,74.5,79.1,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.4,75.4,,,72.4,78.2,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.6,75.6,,,72.5,78.3,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,82.5,82.5,,,73.3,89.1,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,83.2,83.2,,,74.8,89.2,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.2,78.2,,,73.8,82.1,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.5,78.5,,,74.1,82.3,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,53.7,53.7,,,41.4,65.6,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,US,United States,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.9,80.9,***,US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%,76.8,85,Overall,Overall,,59,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,US,United States,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81,81,***,US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%,76.9,85.1,Overall,Overall,,59,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.1,78.1,*,50 States + DC: US Median,76.4,79.6,Overall,Overall,,59,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.8,77.8,*,50 States + DC: US Median,76.1,79.2,Overall,Overall,,59,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,73.2,73.2,,,71.3,75.1,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.1,73.1,,,71.1,75,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,73.5,73.5,,,71.5,75.5,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,73.4,73.4,,,71.3,75.3,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,73.1,73.1,,,62.9,81.3,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,72.5,72.5,,,62.6,80.5,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,63.6,63.6,,,46.5,77.8,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,60.8,60.8,,,45.2,74.5,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,UT,Utah,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80.2,80.2,,,78.1,82.1,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.1,80.1,,,78,82,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.1,78.1,,,75.7,80.3,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.9,77.9,,,75.5,80.2,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,87.7,87.7,,,83.2,91.2,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,87.6,87.6,,,83.1,91,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,73.4,73.4,,,57.2,85.1,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.7,76.7,,,63.6,86.1,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,78.6,78.6,,,76.4,80.7,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.6,78.6,,,76.3,80.8,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.5,79.5,,,77.3,81.6,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,79.6,79.6,,,77.3,81.7,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.4,77.4,,,75.4,79.3,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.5,77.5,,,75.4,79.4,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,77.1,77.1,,,75,79.2,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,77.2,77.2,,,74.9,79.3,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75,75,,,60.9,85.3,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.7,80.7,,,69.3,88.6,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,79.2,79.2,,,69.7,86.4,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,78.2,78.2,,,69,85.2,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.2,75.2,,,59.6,86.2,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,76.9,76.9,,,62.1,87.1,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,80,80,,,77.2,82.6,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,80.1,80.1,,,77.2,82.7,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,81.3,81.3,,,78.7,83.6,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,81.4,81.4,,,78.8,83.8,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,60.9,60.9,,,32.8,83.3,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,68.9,68.9,,,49.3,83.4,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.6,75.6,,,73.2,77.9,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,74.9,74.9,,,72.3,77.3,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,75.8,75.8,,,73.4,78.2,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,75.2,75.2,,,72.6,77.7,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,WHT
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,BLK
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,HIS
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,OTH
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,MRC
2013,2013,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,69.6,69.6,,,66.9,72.2,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.3,69.3,,,66.5,72,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,69.5,69.5,,,66.7,72.2,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,69.2,69.2,,,66.3,72,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,68.5,68.5,,,54.1,80.1,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,67.7,67.7,,,53.1,79.6,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,CrdPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,Mammography use among women aged 50-74 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN1_0,AgeAdjPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.2,78.2,,,74.9,81.2,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.5,78.5,,,75.2,81.4,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.2,82.2,,,78.8,85.2,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.7,82.7,,,79.3,85.6,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,65.7,65.7,,,57,73.4,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,65.6,65.6,,,56.9,73.3,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,68.8,68.8,,,44.2,85.9,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.6,78.6,,,66.1,87.4,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,AK,Alaska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.2,83.2,,,81,85.2,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83,83,,,80.8,84.9,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.7,80.7,,,77.8,83.4,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81,81,,,78,83.6,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,88.7,88.7,,,85.6,91.2,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.7,87.7,,,84.5,90.3,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,73.7,73.7,,,55.8,86.2,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,68.2,68.2,,,53.9,79.8,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.3,79.3,,,68.9,86.8,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79,79,,,69.2,86.3,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.9,80.9,,,68.2,89.4,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.1,81.1,,,69.5,89,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,AL,Alabama,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.1,78.1,,,74.2,81.5,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.8,77.8,,,74.1,81,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.4,76.4,,,71.8,80.4,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,76.5,76.5,,,72.2,80.3,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.9,87.9,,,79.3,93.2,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.9,86.9,,,79.4,92,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,AR,Arkansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.7,79.7,,,77.5,81.8,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.8,79.8,,,77.7,81.8,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.3,80.3,,,77.8,82.6,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.3,80.3,,,77.6,82.8,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83,83,,,66.4,92.4,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.7,84.7,,,71.2,92.6,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.5,80.5,,,75.1,84.9,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.6,80.6,,,76,84.4,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,72.6,72.6,,,64.5,79.4,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,73.2,73.2,,,65.7,79.7,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,AZ,Arizona,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.1,83.1,,,81,85.1,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.7,83.7,,,81.6,85.5,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.6,83.6,,,80.6,86.2,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.2,83.2,,,79.9,86,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.6,83.6,,,73.4,90.4,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85,85,,,75.5,91.2,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.8,86.8,,,83.6,89.5,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.3,87.3,,,84.2,89.8,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,73.1,73.1,,,64.6,80.1,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,75.5,75.5,,,68,81.7,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,CA,California,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.6,84.6,,,83,86.1,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.8,84.8,,,83.2,86.2,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.8,84.8,,,83,86.4,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85,85,,,83.3,86.7,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,72.5,72.5,,,57.7,83.7,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,74.4,74.4,,,60.5,84.6,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.8,85.8,,,81.4,89.2,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.4,86.4,,,82.7,89.4,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81,81,,,69.2,89,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.5,83.5,,,73.9,90,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,CO,Colorado,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.1,87.1,,,85,88.9,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.6,87.6,,,85.5,89.4,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.8,87.8,,,85.4,89.9,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,88.7,88.7,,,86.1,90.9,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.9,87.9,,,80.6,92.7,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,88.3,88.3,,,81.6,92.7,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.6,85.6,,,79.3,90.3,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.7,85.7,,,79.6,90.1,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,88.7,88.7,,,78.2,94.5,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,88.2,88.2,,,77,94.4,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,89.8,89.8,,,81.2,94.7,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,CT,Connecticut,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85,85,,,81.1,88.2,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.7,85.7,,,82.3,88.6,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.9,84.9,,,78.8,89.4,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.2,86.2,,,81.4,89.9,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.1,87.1,,,81.8,91,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,88.2,88.2,,,83.9,91.5,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.5,83.5,,,60.4,94.3,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,90,90,,,76.1,96.2,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.7,84.7,,,65.5,94.1,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,68,68,,,63.6,72.1,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.5,86.5,,,71.5,94.3,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,DC,District of Columbia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.3,86.3,,,83.3,88.9,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.8,86.8,,,84,89.2,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.5,87.5,,,84.1,90.3,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.8,87.8,,,84.2,90.6,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.9,82.9,,,73.5,89.4,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.9,85.9,,,79,90.8,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,91.2,91.2,,,83.8,95.4,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,94,94,,,85.8,97.6,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,96,96,,,90.6,98.3,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,DE,Delaware,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.5,79.5,,,77.3,81.6,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.9,79.9,,,77.7,82,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.9,80.9,,,78.2,83.3,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.8,81.8,,,79,84.3,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.4,79.4,,,71.9,85.3,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.9,79.9,,,72.8,85.6,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.6,78.6,,,73.4,83,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.2,78.2,,,73.1,82.6,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,62.3,62.3,,,48.8,74.2,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,66,66,,,53,77,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.7,79.7,,,77.8,81.5,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80,80,,,78,81.8,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80,80,,,78,81.9,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.8,80.8,,,78.7,82.8,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.2,79.2,,,72.6,84.5,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.5,79.5,,,73.4,84.5,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.3,80.3,,,75,84.8,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.8,80.8,,,75.5,85.1,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,64.7,64.7,,,50.2,76.9,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,65.1,65.1,,,52.3,76.1,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,57.5,57.5,,,39.2,74,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,FL,Florida,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,56.5,56.5,,,40.8,71,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.5,84.5,,,82.1,86.6,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.5,84.5,,,82.2,86.6,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.1,84.1,,,81,86.8,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.5,84.5,,,81.4,87.2,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87,87,,,82.4,90.5,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.5,86.5,,,82,90,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.9,83.9,,,73.2,90.9,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.2,81.2,,,69.6,89.1,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.1,84.1,,,82,86.1,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.2,84.2,,,82.1,86.2,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.8,83.8,,,81,86.3,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.7,83.7,,,80.8,86.3,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.4,87.4,,,83.8,90.3,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.5,87.5,,,84,90.3,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.1,77.1,,,67.2,84.7,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.2,77.2,,,67.3,84.7,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.2,77.2,,,55.9,90.1,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,74.6,74.6,,,55.8,87.3,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,GA,Georgia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,67.9,67.9,,,63.5,72,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,89.9,89.9,,,75.7,96.2,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,90.9,90.9,,,78.3,96.5,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,73.6,73.6,,,58,84.9,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,70.5,70.5,,,56,81.8,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,63.6,63.6,,,58.3,68.6,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,63.4,63.4,,,58.2,68.4,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.6,80.6,,,68.8,88.7,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.5,79.5,,,69.1,87.1,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,GU,Guam,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.1,78.1,,,75.4,80.6,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.9,77.9,,,75.2,80.5,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.1,86.1,,,81.8,89.4,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.9,85.9,,,81.7,89.3,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.4,80.4,,,70.5,87.5,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.5,81.5,,,73.1,87.8,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,72.3,72.3,,,67.3,76.8,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,70.4,70.4,,,65.1,75.2,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.5,79.5,,,74.5,83.7,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.1,80.1,,,75.2,84.3,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.5,82.5,,,79.9,84.8,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.4,82.4,,,79.8,84.7,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.9,86.9,,,82.8,90.1,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.7,86.7,,,82.2,90.2,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.2,85.2,,,74.5,91.9,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.9,87.9,,,81.3,92.4,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.9,78.9,,,74.5,82.7,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.1,78.1,,,73.4,82.2,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.4,83.4,,,78.1,87.7,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,HI,Hawaii,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.7,83.7,,,78.6,87.8,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.4,84.4,,,82.2,86.4,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85,85,,,83,86.9,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.7,84.7,,,82.5,86.7,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.1,85.1,,,83,87,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,91.3,91.3,,,76.9,97.1,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,92.2,92.2,,,81.3,97,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,IA,Iowa,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.1,76.1,,,73,79,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,76.2,76.2,,,73.1,78.9,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.7,76.7,,,73.5,79.6,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,76.9,76.9,,,73.8,79.7,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.1,77.1,,,62.8,87,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,71.5,71.5,,,59.2,81.3,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,ID,Idaho,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.4,81.4,,,78.6,84,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.5,81.5,,,78.8,84,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.5,80.5,,,77.2,83.4,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.5,80.5,,,77.1,83.6,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.6,86.6,,,78.2,92.1,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.4,86.4,,,78.7,91.6,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.4,87.4,,,79.1,92.7,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.7,86.7,,,78.3,92.1,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,59.9,59.9,,,39.1,77.7,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,70.4,70.4,,,57.8,80.5,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,IL,Illinois,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.9,77.9,,,75.9,79.9,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.6,78.6,,,76.7,80.4,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.1,78.1,,,75.8,80.2,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79,79,,,76.8,81,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.4,81.4,,,73.1,87.6,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.3,82.3,,,74.8,88,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.7,76.7,,,67.7,83.8,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.6,77.6,,,68.4,84.8,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,55.9,55.9,,,38.6,71.9,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,61.8,61.8,,,48,73.9,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,IN,Indiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.9,81.9,,,80.2,83.4,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.4,82.4,,,80.8,83.9,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.6,82.6,,,80.8,84.3,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.3,83.3,,,81.5,84.9,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.4,81.4,,,71.9,88.2,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.9,81.9,,,74.4,87.6,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.3,80.3,,,74.3,85.1,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.1,80.1,,,74.2,85,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,71.9,71.9,,,59.2,81.9,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,72.9,72.9,,,61.3,82,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.8,79.8,,,67.2,88.4,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,74.6,74.6,,,60.9,84.8,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,KS,Kansas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.3,81.3,,,79,83.5,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.3,81.3,,,78.9,83.5,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.4,82.4,,,80.1,84.4,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.5,82.5,,,80.2,84.6,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,75.1,75.1,,,59.5,86.1,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,75.2,75.2,,,62.7,84.6,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,KY,Kentucky,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.1,84.1,,,81.8,86.2,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84,84,,,81.8,85.9,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.9,83.9,,,81,86.4,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.8,83.8,,,80.9,86.3,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.4,87.4,,,83.4,90.5,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.7,86.7,,,82.9,89.7,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,71.3,71.3,,,55.6,83.1,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,72.6,72.6,,,58.3,83.4,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,LA,Louisiana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,88,88,,,86.4,89.4,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.9,87.9,,,86.3,89.4,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,90,90,,,88.4,91.4,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,90.3,90.3,,,88.6,91.7,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.8,86.8,,,78.7,92.1,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.4,86.4,,,78.8,91.6,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.6,83.6,,,76.2,89,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.3,83.3,,,75.8,88.8,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,75.3,75.3,,,65.8,82.8,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.5,77.5,,,69.8,83.8,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,89,89,,,77.6,95,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,91.4,91.4,,,83.4,95.8,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MA,Massachusetts,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.7,86.7,,,84.3,88.8,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.7,86.7,,,84.3,88.9,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.7,85.7,,,82.5,88.3,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.4,85.4,,,81.9,88.4,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,91.3,91.3,,,87.1,94.3,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,91.6,91.6,,,87.8,94.3,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,89.1,89.1,,,77.7,95,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,89.7,89.7,,,80.3,94.9,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,72,72,,,57.2,83.2,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,69.6,69.6,,,59.4,78.2,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,91.4,91.4,,,78.5,96.8,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,89.3,89.3,,,75.6,95.8,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MD,Maryland,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85,85,,,83,86.8,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.6,85.6,,,83.5,87.4,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.6,85.6,,,83.6,87.4,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.2,86.2,,,84.1,88,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,ME,Maine,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.4,83.4,,,81.4,85.2,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.6,83.6,,,81.6,85.4,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.9,83.9,,,81.7,85.9,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84,84,,,81.7,86.1,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.9,84.9,,,79,89.3,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.2,85.2,,,79.6,89.4,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.4,85.4,,,73.2,92.6,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.3,83.3,,,67.8,92.2,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,67.7,67.7,,,53,79.6,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,72.9,72.9,,,60.3,82.7,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,68.5,68.5,,,51.2,81.9,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,68.3,68.3,,,53.4,80.1,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MI,Michigan,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.1,86.1,,,84.9,87.2,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.2,86.2,,,85,87.3,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.4,87.4,,,86.2,88.5,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.5,87.5,,,86.3,88.7,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.4,78.4,,,70.2,84.8,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.1,80.1,,,72.6,85.9,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.6,84.6,,,76.9,90.1,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.3,83.3,,,75.1,89.2,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,73.6,73.6,,,64.6,81,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,74.8,74.8,,,65.9,82,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MN,Minnesota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.8,80.8,,,78.1,83.2,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.1,81.1,,,78.5,83.5,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.6,80.6,,,77.7,83.2,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.7,80.7,,,77.7,83.3,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.6,83.6,,,74.4,89.9,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.4,84.4,,,76.2,90.1,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MO,Missouri,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.4,83.4,,,80.3,86.1,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.7,82.7,,,79.6,85.4,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.6,83.6,,,79.2,87.2,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.1,83.1,,,78.8,86.7,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.5,85.5,,,80.9,89.1,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.4,84.4,,,79.8,88.1,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MS,Mississippi,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.1,81.1,,,78.4,83.6,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.7,81.7,,,79.1,84.1,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.3,82.3,,,79.4,84.8,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.9,82.9,,,80.1,85.4,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.8,78.8,,,69,86.2,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.7,77.7,,,68.1,85.1,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,MT,Montana,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.9,85.9,,,84,87.6,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.9,85.9,,,84.1,87.6,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.7,87.7,,,85.5,89.7,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.8,87.8,,,85.6,89.8,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.3,85.3,,,80.9,88.8,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85,85,,,80.5,88.6,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.4,80.4,,,73.6,85.7,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.3,80.3,,,72.6,86.3,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.1,78.1,,,64.4,87.5,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.3,82.3,,,71.2,89.8,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NC,North Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.5,81.5,,,78.5,84.2,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.7,82.7,,,80,85,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.4,83.4,,,80.4,86,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.5,84.5,,,82,86.8,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,66.3,66.3,,,50.4,79.1,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,68.7,68.7,,,55.4,79.5,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,ND,North Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.7,81.7,,,80,83.3,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.9,81.9,,,80.3,83.4,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.5,82.5,,,80.7,84.1,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.9,82.9,,,81.2,84.4,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.9,79.9,,,67.2,88.5,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.5,78.5,,,66.1,87.3,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.1,80.1,,,72.9,85.8,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79,79,,,71.8,84.8,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,74.3,74.3,,,59.7,84.9,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.6,78.6,,,68.6,86.1,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,69.4,69.4,,,50.8,83.3,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,72.2,72.2,,,56.8,83.7,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NE,Nebraska,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.4,85.4,,,82.6,87.7,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.5,85.5,,,82.6,87.9,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.4,85.4,,,82.5,87.8,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.4,85.4,,,82.4,88,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NH,New Hampshire,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.7,83.7,,,81.9,85.3,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.6,83.6,,,81.8,85.3,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.1,85.1,,,83,86.9,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.8,85.8,,,83.5,87.8,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.1,87.1,,,82.9,90.5,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.7,86.7,,,82.3,90.1,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.4,85.4,,,81.5,88.6,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84,84,,,79.8,87.5,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,68,68,,,58.2,76.4,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,67.9,67.9,,,59.4,75.4,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NJ,New Jersey,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.1,79.1,,,76.5,81.4,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.5,79.5,,,77.1,81.8,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.1,81.1,,,77.9,84,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82,82,,,78.5,85,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.6,79.6,,,75.2,83.3,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.3,80.3,,,76.5,83.6,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,74.3,74.3,,,66.7,80.6,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,74.8,74.8,,,67.6,80.9,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NM,New Mexico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.3,78.3,,,73.9,82.2,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.7,78.7,,,74.5,82.4,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.9,81.9,,,77.5,85.5,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.9,82.9,,,78.7,86.5,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78,78,,,68.9,85,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.4,77.4,,,69.2,84,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,63.8,63.8,,,44.1,79.7,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,66.4,66.4,,,47.2,81.4,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NV,Nevada,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.7,82.7,,,80.4,84.8,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83,83,,,80.8,85,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.8,84.8,,,82,87.2,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.4,85.4,,,82.6,87.8,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.2,87.2,,,82,91.1,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.4,87.4,,,82.3,91.1,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.9,85.9,,,80.7,89.9,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.4,85.4,,,80.2,89.4,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,62.9,62.9,,,51.6,72.9,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,67.6,67.6,,,57.5,76.3,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,NY,New York,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.5,81.5,,,79.3,83.5,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82,82,,,79.8,83.9,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.3,81.3,,,79,83.4,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.9,81.9,,,79.6,84,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.7,81.7,,,72.5,88.3,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.4,81.4,,,72.4,88,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.8,86.8,,,72.7,94.2,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.1,86.1,,,73.2,93.4,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,71.8,71.8,,,53.4,84.9,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,70.5,70.5,,,55.2,82.3,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,OH,Ohio,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77,77,,,74.6,79.3,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.4,77.4,,,75.1,79.5,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.5,76.5,,,73.6,79.1,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,76.8,76.8,,,74,79.5,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.6,79.6,,,69.9,86.7,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.3,78.3,,,69.7,85,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.9,81.9,,,73.8,87.9,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.4,84.4,,,77.8,89.3,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.8,76.8,,,69.6,82.7,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.7,77.7,,,71.2,83.1,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,70.9,70.9,,,51,85.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,76.7,76.7,,,65.6,85.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,OK,Oklahoma,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83,83,,,80.3,85.4,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.3,83.3,,,80.6,85.6,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.6,81.6,,,78.6,84.2,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.1,82.1,,,79.1,84.7,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,91.1,91.1,,,81.8,95.9,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,93.7,93.7,,,87.6,97,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.5,86.5,,,74,93.6,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.2,85.2,,,73.2,92.3,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,OR,Oregon,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.6,80.6,,,78.4,82.7,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.3,81.3,,,79.3,83.2,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.5,81.5,,,79.2,83.6,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82,82,,,79.6,84.2,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.4,82.4,,,75.3,87.8,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.2,84.2,,,78.1,88.8,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,79.6,79.6,,,61.7,90.4,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,89,89,,,82.9,93.1,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,54.7,54.7,,,39.1,69.5,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,64.1,64.1,,,50.3,75.9,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.4,77.4,,,75,79.6,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.2,78.2,,,75.9,80.4,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.4,77.4,,,75,79.6,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.2,78.2,,,75.9,80.4,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.8,85.8,,,83.3,88,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.5,86.5,,,84.1,88.5,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.9,85.9,,,83.1,88.3,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.7,86.7,,,83.9,89.1,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.9,80.9,,,63.4,91.1,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.7,85.7,,,76.2,91.8,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,88,88,,,79.7,93.3,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,89.7,89.7,,,83.9,93.6,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81.8,81.8,,,63.5,92.1,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.6,85.6,,,73.5,92.7,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,RI,Rhode Island,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.3,82.3,,,80.3,84.2,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.3,82.3,,,80.3,84.1,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.2,80.2,,,77.4,82.7,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.3,80.3,,,77.6,82.8,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.2,86.2,,,82.9,89,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.9,85.9,,,82.6,88.6,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,90.6,90.6,,,77.4,96.5,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,90.9,90.9,,,81.2,95.9,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,72.5,72.5,,,56.2,84.4,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,71.5,71.5,,,55.8,83.2,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,SC,South Carolina,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.5,84.5,,,81.4,87.2,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.1,85.1,,,82.2,87.6,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.4,85.4,,,82.4,88,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.9,85.9,,,82.9,88.4,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.7,83.7,,,80.3,86.7,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.9,78.9,,,65.4,88.1,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.9,78.9,,,68.8,86.3,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,SD,South Dakota,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.4,85.4,,,82.5,87.9,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.5,85.5,,,82.7,87.9,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.5,83.5,,,80.1,86.5,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,92.2,92.2,,,85.7,95.9,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,90.3,90.3,,,82.4,94.9,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,84.8,84.8,,,82.2,87.1,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.9,84.9,,,82.3,87.2,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.2,82.2,,,79,85,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.3,82.3,,,79,85.2,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,93.1,93.1,,,88.7,95.9,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,92.9,92.9,,,88.7,95.6,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,TN,Tennessee,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.7,77.7,,,75.5,79.7,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.9,77.9,,,75.7,79.9,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.6,80.6,,,77.8,83.2,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.6,80.6,,,77.7,83.2,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.8,80.8,,,73.6,86.4,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.3,80.3,,,72.9,86,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,75.6,75.6,,,71.9,78.9,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,75.5,75.5,,,71.8,78.9,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,69.9,69.9,,,54,82.1,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,75.6,75.6,,,66.5,82.9,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,TX,Texas,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,US,United States,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.7,82.7,*,50 States + DC: US Median,81.3,84.1,Overall,Overall,,59,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.7,82.7,*,50 States + DC: US Median,81.5,84,Overall,Overall,,59,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,US,United States,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.5,82.5,***,US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%,79.3,84.8,Overall,Overall,,59,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,US,United States,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,82.4,82.4,***,US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%,79,84.9,Overall,Overall,,59,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,77.3,77.3,,,75.6,78.8,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,77.8,77.8,,,76.3,79.3,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,78.2,78.2,,,76.4,79.9,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,78.8,78.8,,,77.2,80.3,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,76.8,76.8,,,71.2,81.5,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,75.8,75.8,,,69.8,81,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,67,67,,,56.4,76.1,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,68.7,68.7,,,58.6,77.3,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,UT,Utah,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.2,85.2,,,83.2,87,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.4,85.4,,,83.4,87.1,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.2,85.2,,,82.9,87.2,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.9,85.9,,,83.7,87.8,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86,86,,,80.5,90.1,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.1,86.1,,,80.9,90,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,89,89,,,81.6,93.6,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,90,90,,,83,94.4,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,73.4,73.4,,,61,83,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,73.7,73.7,,,62.5,82.4,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,VA,Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,85.7,85.7,,,83.7,87.4,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.3,86.3,,,84.4,88,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.4,86.4,,,84.5,88.2,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.8,86.8,,,84.8,88.6,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,VT,Vermont,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81,81,,,78.7,83,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.2,81.2,,,79,83.2,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,83.3,83.3,,,81.1,85.2,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,83.5,83.5,,,81.2,85.5,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,82.5,82.5,,,75.1,88,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,84.2,84.2,,,77.6,89.2,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,71.2,71.2,,,60.7,79.8,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,75.2,75.2,,,66.6,82.2,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,68.1,68.1,,,52.1,80.8,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,66.9,66.9,,,52.7,78.6,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,WA,Washington,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.6,86.6,,,84.2,88.6,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,86.8,86.8,,,84.6,88.7,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,87.2,87.2,,,84.9,89.1,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.5,87.5,,,85.2,89.4,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,86.2,86.2,,,65.2,95.4,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,87.8,87.8,,,74.4,94.7,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,89.7,89.7,,,77.2,95.8,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,91.5,91.5,,,81.3,96.4,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,68.3,68.3,,,48.1,83.4,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,71.8,71.8,,,54.7,84.3,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,WI,Wisconsin,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.3,80.3,,,78,82.5,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.9,80.9,,,78.7,83,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.6,80.6,,,78.2,82.8,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,81.2,81.2,,,78.8,83.3,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,WV,West Virginia,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,81,81,,,77.8,83.9,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,80.4,80.4,,,77.3,83.2,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,80.2,80.2,,,76.6,83.3,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,79.8,79.8,,,76.3,82.9,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,89.3,89.3,,,79.3,94.8,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,85.1,85.1,,,74.6,91.7,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,OVERALL,OVR
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,OVERALL,OVR
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,WHT
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,WHT
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,BLK
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,BLK
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,HIS
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,HIS
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,OTH
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,OTH
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,CrdPrev,RACE,MRC
2013,2013,WY,Wyoming,BRFSS,Cancer,Papanicolaou smear use among adult women aged 21-65 years,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_1,AgeAdjPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.3,79.3,,,74.6,83.4,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.2,84.2,,,79,88.4,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,65.7,65.7,,,54.1,75.6,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,AK,Alaska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.3,86.3,,,83.3,88.9,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.9,81.9,,,77.4,85.7,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,93.2,93.2,,,89.7,95.6,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.4,79.4,,,64.8,89,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,AL,Alabama,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.8,80.8,,,75.3,85.4,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.7,78.7,,,71.6,84.3,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,89.5,89.5,,,77.8,95.4,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,AR,Arkansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.3,80.3,,,76.8,83.3,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.1,81.1,,,76.8,84.8,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.7,80.7,,,73.5,86.3,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,74.8,74.8,,,63.4,83.5,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,AZ,Arizona,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.9,81.9,,,78.8,84.6,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.1,81.1,,,76,85.3,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.9,84.9,,,71.2,92.8,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.3,87.3,,,83.2,90.5,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,69.2,69.2,,,58.3,78.4,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,CA,California,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.8,85.8,,,83.5,87.9,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.4,87.4,,,84.8,89.6,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.8,85.8,,,80.2,90,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,74.8,74.8,,,58.6,86.2,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,CO,Colorado,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.3,88.3,,,84.9,91,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,89.8,89.8,,,85.2,93.2,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.3,85.3,,,74.4,92.1,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.9,85.9,,,78,91.3,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,CT,Connecticut,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.7,84.7,,,79.2,89,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.8,83.8,,,75.5,89.7,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,90.4,90.4,,,82,95.1,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,DC,District of Columbia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.1,84.1,,,79.1,88,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.5,87.5,,,81.6,91.7,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76.5,76.5,,,63.5,85.9,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,92.6,92.6,,,83.9,96.8,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,DE,Delaware,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.7,80.7,,,77.3,83.6,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.4,83.4,,,78.9,87,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76.7,76.7,,,66.3,84.6,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.4,81.4,,,74.8,86.6,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.2,81.2,,,78.4,83.8,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.3,83.3,,,80.2,86,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.1,80.1,,,71.5,86.6,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.1,79.1,,,71.7,85,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,60.2,60.2,,,42,76,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,FL,Florida,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,68.7,68.7,,,44.6,85.6,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.6,86.6,,,83.3,89.4,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.1,86.1,,,81.3,89.8,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.3,88.3,,,82.1,92.6,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.7,84.7,,,81.5,87.3,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.1,83.1,,,78.7,86.8,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,89.9,89.9,,,85.2,93.3,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.8,78.8,,,67.2,87.1,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,GA,Georgia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,67.3,67.3,,,61.6,72.6,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,61.2,61.2,,,54.2,67.8,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.9,81.9,,,66.8,91,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,GU,Guam,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,75.8,75.8,,,71.6,79.5,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.9,87.9,,,80.1,92.9,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.8,79.8,,,66.8,88.6,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,65.4,65.4,,,57.3,72.7,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,77.7,77.7,,,70.9,83.4,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.5,81.5,,,77.7,84.8,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.2,86.2,,,78.9,91.3,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.2,82.2,,,68.1,90.9,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76.1,76.1,,,69.2,81.9,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,HI,Hawaii,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85,85,,,77.8,90.1,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.1,85.1,,,81.7,88,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.9,85.9,,,82.4,88.8,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,90.8,90.8,,,74.3,97.1,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,IA,Iowa,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.2,79.2,,,74.9,82.9,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.7,79.7,,,75.3,83.5,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.5,81.5,,,63.7,91.7,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,ID,Idaho,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.2,82.2,,,77.8,85.9,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.1,82.1,,,76.7,86.5,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.4,86.4,,,73.5,93.6,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.9,88.9,,,78.5,94.6,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,IL,Illinois,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.3,79.3,,,76.2,82.1,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.2,80.2,,,76.6,83.3,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.4,79.4,,,68,87.4,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76.2,76.2,,,65.8,84.2,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,IN,Indiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.3,83.3,,,80.8,85.5,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.5,84.5,,,81.7,86.9,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.5,82.5,,,67.7,91.4,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.1,81.1,,,74,86.6,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,KS,Kansas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.1,84.1,,,80.6,87.1,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86,86,,,82.8,88.7,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,72.8,72.8,,,49.6,88,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,KY,Kentucky,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86,86,,,82.8,88.7,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.2,86.2,,,81.8,89.6,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.4,88.4,,,83.1,92.3,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,LA,Louisiana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.1,86.1,,,83.4,88.5,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,89.8,89.8,,,86.9,92.2,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85,85,,,73.5,92,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78,78,,,67.1,86.1,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,70.4,70.4,,,58.5,80.1,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MA,Massachusetts,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86,86,,,81.9,89.3,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.7,83.7,,,77.5,88.5,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,93,93,,,86,96.6,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.7,87.7,,,73.5,94.8,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,67.2,67.2,,,46.2,83,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MD,Maryland,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.6,85.6,,,82.1,88.5,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.6,86.6,,,83,89.5,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,ME,Maine,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.7,82.7,,,79.6,85.4,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.9,82.9,,,79.2,86.1,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.6,84.6,,,76.3,90.4,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.9,86.9,,,73.1,94.2,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MI,Michigan,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.1,86.1,,,84.3,87.8,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.2,88.2,,,86.4,89.9,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76.6,76.6,,,66.2,84.6,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.3,86.3,,,77.4,92.1,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,73.5,73.5,,,62.9,82,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MN,Minnesota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.4,81.4,,,77.4,84.9,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.1,81.1,,,76.7,84.9,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MO,Missouri,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.8,87.8,,,83.7,91,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,89.2,89.2,,,83.1,93.2,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.4,88.4,,,82.4,92.5,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MS,Mississippi,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.6,83.6,,,79.5,87,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.5,85.5,,,81.1,89,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.7,78.7,,,65,88.1,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,MT,Montana,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.8,85.8,,,83.2,88.1,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88,88,,,84.6,90.8,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.9,86.9,,,80.8,91.3,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.3,80.3,,,72.8,86.2,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NC,North Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.1,83.1,,,78.4,86.9,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86,86,,,81.3,89.8,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,64.6,64.6,,,44.9,80.3,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,ND,North Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.9,81.9,,,79.3,84.3,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.9,82.9,,,80.1,85.5,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.4,84.4,,,68.7,93.1,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.4,80.4,,,71.8,86.9,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,69.6,69.6,,,49.2,84.3,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NE,Nebraska,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84,84,,,79,88,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.6,83.6,,,78.4,87.8,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NH,New Hampshire,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.9,83.9,,,81.2,86.2,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.6,87.6,,,84.1,90.5,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.7,85.7,,,79.2,90.4,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.8,85.8,,,80.7,89.7,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,63.6,63.6,,,50.9,74.7,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76,76,,,64.8,84.5,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NJ,New Jersey,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.3,79.3,,,75.4,82.7,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.2,84.2,,,78.8,88.4,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.6,79.6,,,73.5,84.5,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,71.8,71.8,,,60.9,80.6,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NM,New Mexico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.2,79.2,,,72.7,84.4,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.1,88.1,,,82.1,92.2,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NV,Nevada,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.4,81.4,,,77.8,84.5,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.9,85.9,,,81.1,89.7,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.4,86.4,,,78.9,91.6,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.7,82.7,,,75,88.3,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,57.4,57.4,,,43.7,70.1,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,NY,New York,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.9,82.9,,,79.6,85.8,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.3,83.3,,,79.7,86.4,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.5,80.5,,,66.5,89.5,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,OH,Ohio,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.2,79.2,,,75.7,82.4,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.4,80.4,,,76.1,84.2,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.8,78.8,,,64.5,88.3,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.7,80.7,,,71.1,87.6,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.7,78.7,,,69.4,85.8,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,OK,Oklahoma,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.4,85.4,,,81.4,88.6,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.6,85.6,,,81.2,89.1,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.8,87.8,,,75.5,94.4,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,OR,Oregon,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.1,81.1,,,77.5,84.3,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.7,83.7,,,79.8,87,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.1,82.1,,,72.3,89,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,PA,Pennsylvania,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,77.1,77.1,,,73.8,80.1,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,77.1,77.1,,,73.8,80.1,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,PR,Puerto Rico,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.2,85.2,,,81,88.6,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.2,86.2,,,81,90.1,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.7,86.7,,,75.2,93.3,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,RI,Rhode Island,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.9,84.9,,,82,87.4,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.7,81.7,,,77.4,85.3,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,90,90,,,85.7,93.2,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,90.6,90.6,,,74.6,97,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,SC,South Carolina,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.5,86.5,,,81.8,90.2,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.8,87.8,,,83.4,91.1,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.5,83.5,,,64.9,93.3,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,SD,South Dakota,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.8,86.8,,,82.4,90.2,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.6,84.6,,,79.1,88.9,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,93.3,93.3,,,83.2,97.5,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.2,86.2,,,82.4,89.4,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.1,83.1,,,78.1,87.1,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,94.8,94.8,,,88.5,97.7,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,TN,Tennessee,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.2,78.2,,,75.3,80.9,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.1,83.1,,,78.9,86.6,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.4,80.4,,,70.7,87.4,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,76.9,76.9,,,72.6,80.7,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,65.5,65.5,,,47.8,79.7,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,TX,Texas,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,US,United States,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84,84,*,50 States + DC: US Median,82.2,85.1,Overall,Overall,,59,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,US,United States,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,81.5,81.5,***,US Median based on the number of participating states and/or excluding states with sample size below 50 or relative standard error above 30%,79.4,86.2,Overall,Overall,,59,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,77.4,77.4,,,75.3,79.4,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.4,78.4,,,76.1,80.5,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,78.4,78.4,,,72.1,83.6,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,66.3,66.3,,,53.4,77.1,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,UT,Utah,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.9,85.9,,,82.9,88.4,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87.6,87.6,,,84.1,90.4,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.1,85.1,,,76.6,90.9,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88,88,,,79,93.4,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,69.6,69.6,,,53.7,81.9,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,VA,Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,VI,Virgin Islands,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,85.7,85.7,,,82.4,88.5,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,86.3,86.3,,,83,89.1,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,VT,Vermont,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,79.1,79.1,,,75.6,82.2,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,83.5,83.5,,,79.9,86.6,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,80.5,80.5,,,71.5,87.2,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,66.8,66.8,,,53.6,77.8,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,WA,Washington,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,87,87,,,83.3,89.9,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,88.6,88.6,,,85,91.5,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,WI,Wisconsin,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.3,84.3,,,81,87.1,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.5,84.5,,,81,87.4,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.9,57.9,,,54.9,60.8,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,WV,West Virginia,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,84.4,84.4,,,79.5,88.3,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,82.8,82.8,,,77,87.4,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,MRC
2013,2013,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,OVERALL,OVR
2013,2013,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,WHT
2013,2013,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,BLK
2013,2013,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,HIS
2013,2013,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,OTH
2013,2013,WY,Wyoming,BRFSS,Cancer,Recent Papanicolaou smear use among women aged 21-44 years,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN2_2,CrdPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,55.7,61.4,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,51.9,60.4,Gender,Male,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.4,57.4,,,53.2,61.5,Gender,Male,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,55.6,63.7,Gender,Female,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.9,59.9,,,55.9,63.7,Gender,Female,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.9,57.9,,,54.9,60.9,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,55.6,61.5,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.9,56.9,,,47.4,66,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56,56,,,47.2,64.5,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.7,69.7,,,51,83.5,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.5,70.5,,,53.3,83.4,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60.7,64.6,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.9,61.9,,,60,63.8,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,57.9,64.3,Gender,Male,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61,61,,,57.8,64,Gender,Male,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,61.7,66.3,Gender,Female,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.8,62.8,,,60.5,65,Gender,Female,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,61.8,66.1,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,60.4,64.7,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.8,61.8,,,57.6,65.8,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,58.2,66.1,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,34.3,34.3,,,21.3,50.3,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,39,39,,,29.1,49.8,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.2,52.2,,,34.4,69.5,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.1,50.1,,,34.5,65.7,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.4,58.4,,,55.8,61,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.1,57.1,,,54.4,59.8,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,51.5,59.9,Gender,Male,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.9,54.9,,,50.7,59.1,Gender,Male,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,57.6,64,Gender,Female,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.2,59.2,,,55.9,62.5,Gender,Female,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59,59,,,56.1,61.8,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.1,57.1,,,54.2,60,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,47.8,63.4,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.3,57.3,,,49.8,64.4,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73,73,,,57.4,84.4,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.2,70.2,,,57.3,80.5,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,59.6,62.9,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60,60,,,58.3,61.7,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.8,59.8,,,57.2,62.4,Gender,Male,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.5,58.5,,,55.8,61.1,Gender,Male,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.5,64.6,Gender,Female,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.4,61.4,,,59.2,63.5,Gender,Female,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.4,64.4,,,62.7,66.1,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,60.8,64.4,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,53.1,73.7,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.6,63.6,,,54,72.3,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.2,50.2,,,44.8,55.6,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51.5,51.5,,,46.4,56.5,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.3,50.3,,,42.3,58.3,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.3,50.3,,,42.6,58.1,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.1,67.1,,,50.1,80.5,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.1,71.1,,,57.1,81.9,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,58.8,63.3,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.6,60.6,,,58.4,62.8,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.1,59.1,,,55.8,62.4,Gender,Male,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.6,59.6,,,56.4,62.7,Gender,Male,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.9,62.9,,,59.7,66,Gender,Female,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,58.6,64.9,Gender,Female,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.4,67.4,,,64.8,69.9,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.9,65.9,,,63.4,68.4,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73,73,,,64.3,80.2,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.4,72.4,,,64.2,79.4,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,44.8,44.8,,,39.9,49.8,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,45,45,,,40.1,50,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.6,57.6,,,48.3,66.4,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.8,55.8,,,47,64.1,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.5,58.5,,,42.4,73,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,46.8,74.9,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,63.1,66,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,62.6,65.4,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.4,64.7,Gender,Male,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,59.7,63.9,Gender,Male,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.4,66.4,,,64.4,68.3,Gender,Female,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66,66,,,64.1,67.9,Gender,Female,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.2,66.2,,,64.7,67.8,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.4,65.4,,,63.9,66.9,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.7,72.7,,,63.4,80.4,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,60.9,78.3,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.5,52.5,,,47.2,57.7,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.7,53.7,,,48.6,58.6,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.8,64.8,,,53.4,74.7,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.1,68.1,,,58.1,76.6,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.7,56.7,,,43.2,69.2,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,44.1,67,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.9,70.9,,,69,72.8,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.8,70.8,,,68.8,72.6,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.5,69.5,,,66.6,72.3,Gender,Male,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.4,69.4,,,66.6,72.2,Gender,Male,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.2,72.2,,,69.6,74.7,Gender,Female,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72,72,,,69.3,74.5,Gender,Female,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.7,72.7,,,70.5,74.7,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.2,72.2,,,70.1,74.2,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.7,69.7,,,61.6,76.8,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.2,69.2,,,61.2,76.2,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.2,60.2,,,51.6,68.3,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.2,63.2,,,55,70.7,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.4,59.4,,,44.4,72.8,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.5,58.5,,,45.6,70.2,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,60.6,67.2,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.8,63.8,,,60.5,67.1,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.7,61.7,,,56.1,67,Gender,Male,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.1,62.1,,,56.6,67.4,Gender,Male,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66,66,,,61.9,69.8,Gender,Female,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.3,65.3,,,61.3,69.1,Gender,Female,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.2,71.2,,,66.6,75.4,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,65.7,74.6,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.6,58.6,,,53.5,63.5,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.8,58.8,,,53.8,63.7,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,38.4,71.8,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57,57,,,41.6,71.1,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.8,68.8,,,66.2,71.2,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.1,68.1,,,65.6,70.5,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,63.1,71.1,Gender,Male,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.5,66.5,,,62.5,70.3,Gender,Male,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.2,70.2,,,67,73.2,Gender,Female,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.6,69.6,,,66.4,72.6,Gender,Female,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.7,70.7,,,68,73.3,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.6,69.6,,,66.8,72.3,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,56.3,71.1,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.8,64.8,,,57.8,71.2,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,40,71.3,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.5,62.5,,,50.3,73.3,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,53.8,73.2,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.5,62.5,,,52.4,71.5,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.2,64.2,,,62.3,66,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.5,62.5,,,60.7,64.3,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,58.3,64.1,Gender,Male,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.9,59.9,,,57.1,62.7,Gender,Male,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.8,66.8,,,64.5,69,Gender,Female,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.8,64.8,,,62.6,67.1,Gender,Female,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.9,67.9,,,65.9,69.8,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.1,65.1,,,63.1,67,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,,,59.5,71.5,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,61.4,72.3,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.7,52.7,,,46.7,58.6,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.1,53.1,,,47.6,58.4,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.3,50.3,,,37.5,63,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.6,52.6,,,40.6,64.3,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.1,58.1,,,43,71.9,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.5,57.5,,,42.8,71,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,61.7,66.2,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.8,63.8,,,61.6,66,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.3,62.3,,,58.7,65.8,Gender,Male,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,58.8,65.7,Gender,Male,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.4,65.4,,,62.6,68.2,Gender,Female,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62.4,67.9,Gender,Female,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66,66,,,63.4,68.5,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,62.4,67.6,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66,66,,,61.4,70.4,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.1,66.1,,,61.5,70.5,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,25.9,25.9,,,15.9,39.3,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,32.7,32.7,,,21.4,46.3,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,40.7,40.7,,,36.4,45.1,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,41.5,41.5,,,37.1,45.9,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,43.7,43.7,,,37.4,50.2,Gender,Male,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,44.5,44.5,,,38.4,50.9,Gender,Male,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37.5,37.5,,,31.8,43.5,Gender,Female,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,38.2,38.2,,,32.5,44.2,Gender,Female,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.2,60.2,,,44.9,73.8,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.4,58.4,,,45.2,70.4,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,49.8,49.8,,,35.6,64,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.2,50.2,,,38.3,62,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37,37,,,31.9,42.4,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,37.1,37.1,,,32,42.5,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,38.9,38.9,,,27.7,51.4,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,36.7,36.7,,,26,48.8,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.1,66.1,,,63.8,68.4,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62.8,67.5,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,60.7,67.3,Gender,Male,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.6,63.6,,,60.3,66.8,Gender,Male,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,64.9,71.2,Gender,Female,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.7,66.7,,,63.4,69.9,Gender,Female,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.9,67.9,,,64.1,71.5,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.9,66.9,,,63,70.6,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65,65,,,55.9,73,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,57.6,74,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.5,66.5,,,62.7,70.2,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,61.1,68.8,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.7,64.7,,,60.3,68.9,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.4,64.4,,,60,68.7,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,,,64,67.6,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.1,65.1,,,63.2,66.8,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.8,63.8,,,61,66.5,Gender,Male,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.2,63.2,,,60.4,65.9,Gender,Male,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.7,67.7,,,65.3,70,Gender,Female,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.9,66.9,,,64.5,69.2,Gender,Female,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.1,67.1,,,65.3,68.9,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,64.5,68.1,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.5,47.5,,,31.3,64.3,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,48.7,48.7,,,34.1,63.6,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.1,59.1,,,56.6,61.6,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.7,57.7,,,55.3,60.1,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57,57,,,53.1,60.8,Gender,Male,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.5,55.5,,,51.7,59.3,Gender,Male,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,57.8,64.4,Gender,Female,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.7,59.7,,,56.6,62.7,Gender,Female,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,58.3,63.5,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.1,59.1,,,56.5,61.6,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,46.4,46.4,,,32.6,60.9,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,48.6,48.6,,,36.4,61,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.5,60.5,,,57.9,63,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.3,60.3,,,57.8,62.8,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.1,60.1,,,56.1,64.1,Gender,Male,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,55.6,63.4,Gender,Male,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.8,60.8,,,57.5,64,Gender,Female,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.9,60.9,,,57.7,64.1,Gender,Female,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60,65.3,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,59.6,64.9,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.4,56.4,,,48.1,64.4,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,48.2,63.3,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.2,50.2,,,38.8,61.6,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51.2,51.2,,,40.2,62.2,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.7,58.7,,,42.3,73.3,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.2,52.2,,,38.1,66,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,58,61.2,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,57.9,61.1,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.1,57.1,,,54.5,59.5,Gender,Male,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.2,57.2,,,54.8,59.7,Gender,Male,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62,62,,,60,64.1,Gender,Female,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,59.4,63.5,Gender,Female,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.3,60.3,,,58.6,62,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60,60,,,58.4,61.7,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.2,58.2,,,50.9,65.1,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.8,58.8,,,51.5,65.7,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,42.8,42.8,,,29.9,56.8,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.4,46.4,,,34.1,59.3,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,43.2,74.2,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.5,60.5,,,46.5,73,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.5,52.5,,,35.5,68.9,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.2,52.2,,,34.6,69.3,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.3,62.3,,,60.9,63.7,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,60.1,62.8,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.6,61.6,,,59.5,63.7,Gender,Male,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.8,60.8,,,58.8,62.9,Gender,Male,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63,63,,,61.2,64.8,Gender,Female,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.1,62.1,,,60.3,63.9,Gender,Female,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.2,64.2,,,62.7,65.6,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.9,62.9,,,61.5,64.3,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.8,57.8,,,50.4,64.8,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,51.5,65.4,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37.8,37.8,,,30.3,45.9,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,40.2,40.2,,,32.5,48.4,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,45.4,66.4,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.1,55.1,,,44.7,65.1,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,45.1,65.8,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55,55,,,44.4,65.3,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.9,64.9,,,62.9,66.8,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,61.9,65.8,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.4,62.4,,,59.2,65.6,Gender,Male,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,58.6,64.8,Gender,Male,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,64.8,69.4,Gender,Female,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.1,66.1,,,63.7,68.4,Gender,Female,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.2,65.2,,,63.2,67.2,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.1,64.1,,,62.1,66.1,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,51.9,71.3,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,52.3,70.5,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.7,60.7,,,40.5,77.7,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,44.5,76.5,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,39.9,39.9,,,24.1,58,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,42.9,42.9,,,32.1,54.5,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.4,61.4,,,59.4,63.3,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.7,60.7,,,58.8,62.7,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.2,58.2,,,55,61.4,Gender,Male,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58,58,,,54.9,61,Gender,Male,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,61.7,66.6,Gender,Female,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.2,63.2,,,60.8,65.6,Gender,Female,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,59.7,64.4,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.6,60.6,,,58.3,62.9,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.4,60.4,,,56.4,64.3,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61,61,,,57.1,64.8,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,41.3,41.3,,,26.2,58.2,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,43.8,43.8,,,31.2,57.2,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,47.7,74.6,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,45.5,70.5,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.6,72.6,,,71,74.2,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.5,72.5,,,70.9,74,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.3,72.3,,,69.9,74.6,Gender,Male,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.2,72.2,,,69.8,74.6,Gender,Male,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73,73,,,70.8,75,Gender,Female,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.7,72.7,,,70.6,74.7,Gender,Female,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,74.6,74.6,,,73,76.2,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,74.3,74.3,,,72.7,75.9,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.4,62.4,,,53.2,70.7,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.3,61.3,,,52.5,69.4,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.1,60.1,,,51.2,68.3,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.8,62.8,,,54.2,70.6,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,50.9,72.2,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,53.7,73,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,74.8,74.8,,,61.5,84.6,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,73.9,73.9,,,61.2,83.6,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.6,68.6,,,66.7,70.5,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.6,68.6,,,66.8,70.3,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.3,67.3,,,64.1,70.4,Gender,Male,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.6,67.6,,,64.7,70.3,Gender,Male,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.8,69.8,,,67.4,72.1,Gender,Female,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.5,69.5,,,67.2,71.7,Gender,Female,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.4,69.4,,,67.3,71.5,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.7,68.7,,,66.6,70.7,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.9,67.9,,,63.3,72.1,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,66.5,73.9,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.6,64.6,,,48.5,77.9,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,51.2,75,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.3,64.3,,,53.5,73.9,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.4,59.4,,,50.4,67.9,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.1,73.1,,,58,84.2,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.2,68.2,,,55.7,78.5,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.4,73.4,,,71.8,75,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.6,72.6,,,70.9,74.3,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.2,71.2,,,68.5,73.8,Gender,Male,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,67.5,72.9,Gender,Male,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,75.5,75.5,,,73.5,77.4,Gender,Female,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,74.8,74.8,,,72.7,76.8,Gender,Female,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,74.2,74.2,,,72.5,75.8,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,73.4,73.4,,,71.7,75.1,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.3,54.3,,,39.4,68.4,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.2,52.2,,,38.5,65.5,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.8,68.8,,,67.1,70.5,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.4,68.4,,,66.7,70,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67,67,,,64.3,69.5,Gender,Male,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,64.4,69.4,Gender,Male,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.6,70.6,,,68.3,72.7,Gender,Female,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.9,69.9,,,67.6,72,Gender,Female,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.6,69.6,,,67.7,71.3,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.1,69.1,,,67.2,70.8,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.8,69.8,,,63.8,75.2,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.7,69.7,,,64.1,74.9,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.3,66.3,,,50.7,79,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.2,66.2,,,48.8,80.1,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.8,50.8,,,35.5,65.8,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.3,57.3,,,45.1,68.7,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.5,56.5,,,42.1,69.9,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58,58,,,45.3,69.7,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.7,68.7,,,67.4,69.9,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.4,68.4,,,67.2,69.6,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.4,66.4,,,64.5,68.2,Gender,Male,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,64.5,68.2,Gender,Male,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.9,70.9,,,69.2,72.5,Gender,Female,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.4,70.4,,,68.8,72,Gender,Female,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.8,69.8,,,68.6,71.1,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.4,69.4,,,68.2,70.6,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.5,63.5,,,53.8,72.2,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.4,66.4,,,57.8,74.1,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.8,51.8,,,40.1,63.3,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,48.8,69.3,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,49.8,49.8,,,38.9,60.6,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.6,50.6,,,41.8,59.3,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.7,69.7,,,52.3,82.8,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.8,70.8,,,55,82.7,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.8,59.8,,,57.5,62,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.4,59.4,,,57.1,61.6,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.6,54.6,,,51.1,58,Gender,Male,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.2,54.2,,,50.7,57.7,Gender,Male,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,61.5,67.3,Gender,Female,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,61,66.7,Gender,Female,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.2,60.2,,,57.8,62.6,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,57,61.8,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.7,61.7,,,53.6,69.3,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,54,69.9,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,34.9,75.4,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,48.1,48.1,,,33.4,63.1,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.3,65.3,,,47.9,79.5,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.2,61.2,,,47.4,73.4,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.7,57.7,,,54.9,60.4,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.1,57.1,,,54.4,59.7,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.7,56.7,,,52.2,61.1,Gender,Male,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.3,56.3,,,52,60.5,Gender,Male,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.5,58.5,,,55.1,61.9,Gender,Female,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.9,57.9,,,54.6,61.2,Gender,Female,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,56.1,63,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.2,58.2,,,54.8,61.5,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.7,54.7,,,49.8,59.4,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.7,55.7,,,51.2,60.1,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.1,60.1,,,58,62.2,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.2,58.2,,,56,60.3,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.5,59.5,,,56.4,62.6,Gender,Male,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.3,57.3,,,54.2,60.4,Gender,Male,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.7,60.7,,,57.7,63.6,Gender,Female,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.1,59.1,,,56.1,62,Gender,Female,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,59,63.5,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.1,59.1,,,56.8,61.3,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,41.5,77.4,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,44.3,76.3,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,41.8,41.8,,,33.3,50.7,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,43.8,43.8,,,36.6,51.3,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.5,54.5,,,37.6,70.4,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.8,58.8,,,43.9,72.3,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.5,68.5,,,66.6,70.3,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.3,67.3,,,65.4,69.2,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65,65,,,62.1,67.8,Gender,Male,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,60.8,66.8,Gender,Male,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.4,71.4,,,68.9,73.7,Gender,Female,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,67.8,72.6,Gender,Female,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.2,70.2,,,68,72.2,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.6,68.6,,,66.3,70.8,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.2,68.2,,,63.8,72.3,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.5,67.5,,,63.2,71.6,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,31.5,31.5,,,21.8,43,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,31.8,31.8,,,21.6,44,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,48.7,72.6,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.4,60.4,,,49.1,70.7,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,57.5,61.9,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,57.1,61.4,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.3,58.3,,,55,61.6,Gender,Male,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58,58,,,54.7,61.2,Gender,Male,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,58.3,63.9,Gender,Female,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.6,60.6,,,57.8,63.4,Gender,Female,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.6,60.6,,,58.4,62.8,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.9,59.9,,,57.6,62.1,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.5,51.5,,,37.8,65,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.1,53.1,,,40.2,65.6,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.4,62.4,,,61,63.7,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,60.4,63.1,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.2,61.2,,,59.2,63.3,Gender,Male,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.7,60.7,,,58.6,62.8,Gender,Male,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.4,63.4,,,61.6,65.2,Gender,Female,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.7,62.7,,,60.9,64.6,Gender,Female,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.6,63.6,,,62.2,65,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.9,62.9,,,61.5,64.3,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.3,63.3,,,52.1,73.2,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62,62,,,51.6,71.3,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,32.2,32.2,,,24.4,41.1,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,34.1,34.1,,,26.5,42.7,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.4,58.4,,,46,69.9,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,49.7,68.5,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.1,59.1,,,40.5,75.3,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,46.6,70.9,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71,71,,,68.8,73,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.8,70.8,,,68.7,72.8,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.8,70.8,,,67.4,74,Gender,Male,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.5,70.5,,,67.3,73.6,Gender,Male,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.1,71.1,,,68.3,73.8,Gender,Female,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.1,71.1,,,68.3,73.7,Gender,Female,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.5,71.5,,,69.2,73.6,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.3,71.3,,,69.1,73.3,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.5,52.5,,,35,69.4,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.4,54.4,,,38.6,69.4,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,60.6,64.4,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,60.8,64.3,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.4,63.4,,,60.6,66,Gender,Male,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.6,63.6,,,61,66.2,Gender,Male,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.8,61.8,,,59.2,64.3,Gender,Female,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.7,61.7,,,59.3,64.1,Gender,Female,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.4,65.4,,,63.4,67.4,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.6,64.6,,,62.6,66.5,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61,61,,,55.4,66.4,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,57.2,67.6,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.3,54.3,,,47.9,60.6,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.2,57.2,,,51.2,62.9,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.4,52.4,,,42.5,62.2,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53,53,,,44,61.7,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,57.5,61.6,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.9,58.9,,,56.8,60.9,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.5,59.5,,,56.4,62.6,Gender,Male,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.2,59.2,,,56,62.2,Gender,Male,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,56.9,62.3,Gender,Female,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.7,58.7,,,55.9,61.4,Gender,Female,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.3,64.3,,,61.8,66.7,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.9,62.9,,,60.3,65.5,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.1,73.1,,,56.6,85,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,76.3,76.3,,,63.2,85.7,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53,53,,,49,56.9,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.5,52.5,,,48.6,56.5,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53.2,53.2,,,45.3,60.8,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.6,54.6,,,47,62,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.5,57.5,,,53.9,61.1,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.3,56.3,,,52.9,59.7,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53.7,53.7,,,48.1,59.2,Gender,Male,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.6,53.6,,,48.3,58.8,Gender,Male,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.2,61.2,,,56.5,65.7,Gender,Female,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.4,58.4,,,54.1,62.5,Gender,Female,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.4,61.4,,,57.7,65.1,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.1,60.1,,,56.4,63.7,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.8,61.8,,,45.6,75.8,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.7,58.7,,,43.3,72.6,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37.1,37.1,,,26.1,49.7,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,42.6,42.6,,,32.1,53.7,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.9,50.9,,,34.6,67,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.7,46.7,,,36.3,57.5,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.8,56.8,,,31.1,79.3,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.1,55.1,,,42.3,67.2,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.7,65.7,,,63.6,67.8,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.3,65.3,,,63.1,67.4,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,60.8,67.3,Gender,Male,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,60.6,67,Gender,Male,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,64.3,69.9,Gender,Female,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,63.5,69,Gender,Female,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.2,68.2,,,65.8,70.5,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.4,67.4,,,65,69.7,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.6,65.6,,,59.3,71.4,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.7,65.7,,,59.7,71.3,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,52,67,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.3,60.3,,,52.6,67.5,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.6,54.6,,,42.5,66.3,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.2,56.2,,,45.6,66.3,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.9,62.9,,,61,64.7,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.4,62.4,,,60.5,64.2,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.1,63.1,,,60.2,66,Gender,Male,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,59.7,65.4,Gender,Male,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60.3,65,Gender,Female,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.2,62.2,,,59.8,64.5,Gender,Female,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60.7,64.6,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62,62,,,60,63.9,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.6,68.6,,,61.5,75,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.7,69.7,,,63,75.6,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.4,52.4,,,35.3,69,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.1,56.1,,,44,67.5,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,43.8,43.8,,,29.2,59.6,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.3,46.3,,,32.4,60.9,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.5,56.5,,,54.7,58.3,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,54.1,57.6,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.8,52.8,,,50,55.6,Gender,Male,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.7,52.7,,,50,55.4,Gender,Male,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.9,59.9,,,57.6,62.2,Gender,Female,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.9,58.9,,,56.6,61.2,Gender,Female,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.9,57.9,,,55.9,59.9,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.7,56.7,,,54.7,58.7,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.4,58.4,,,50.5,65.8,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.6,57.6,,,49.7,65.1,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,34.5,34.5,,,25,45.6,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,36.2,36.2,,,26.2,47.6,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.1,55.1,,,47.5,62.6,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.6,55.6,,,48.9,62.1,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.3,51.3,,,43.4,59.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.2,53.2,,,46.1,60.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.4,63.4,,,61,65.7,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.2,62.2,,,59.8,64.6,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.3,60.3,,,56.5,63.9,Gender,Male,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,55.7,62.8,Gender,Male,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.3,66.3,,,63.3,69.1,Gender,Female,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62,68.2,Gender,Female,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.8,64.8,,,62.4,67.1,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.5,63.5,,,60.9,65.9,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.4,52.4,,,37.9,66.6,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.6,53.6,,,39.7,67.1,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,43.5,43.5,,,27.2,61.3,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,45.9,45.9,,,30.8,61.7,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.6,63.6,,,52.2,73.6,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.1,60.1,,,49.7,69.6,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,62.8,66.2,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,62.3,65.7,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63,63,,,60.4,65.6,Gender,Male,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.8,62.8,,,60.1,65.4,Gender,Male,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,,,63.6,68,Gender,Female,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62.9,67.4,Gender,Female,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.7,65.7,,,63.9,67.4,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,63.2,66.8,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.2,62.2,,,55.7,68.4,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.2,61.2,,,54.8,67.3,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.6,51.6,,,37.2,65.7,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,49,49,,,36.1,62.1,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.3,52.3,,,36.3,67.8,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.1,56.1,,,41.5,69.7,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.6,51.6,,,49.3,53.9,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.8,50.8,,,48.5,53.2,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.1,51.1,,,47.3,54.9,Gender,Male,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.4,50.4,,,46.6,54.3,Gender,Male,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52,52,,,49.2,54.8,Gender,Female,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51.3,51.3,,,48.6,54.1,Gender,Female,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.5,51.5,,,49.1,53.8,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.6,50.6,,,48.3,53,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.5,71.5,,,69.5,73.5,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.1,71.1,,,69.1,73.1,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.9,71.9,,,68.7,74.8,Gender,Male,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.6,71.6,,,68.3,74.6,Gender,Male,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.3,71.3,,,68.7,73.7,Gender,Female,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.7,70.7,,,68.1,73.2,Gender,Female,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.5,73.5,,,71.4,75.5,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.9,72.9,,,70.8,74.9,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.7,66.7,,,51.7,78.9,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.9,66.9,,,53.3,78.1,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.7,58.7,,,48.9,67.8,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.7,58.7,,,49,67.7,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.8,62.8,,,48.4,75.3,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.5,60.5,,,46.5,73,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.1,65.1,,,63.5,66.7,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.8,63.8,,,62.1,65.5,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.1,65,Gender,Male,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.1,61.1,,,58.6,63.6,Gender,Male,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.3,67.3,,,65.1,69.4,Gender,Female,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.1,66.1,,,63.9,68.3,Gender,Female,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67,67,,,65,68.8,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,63,67,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.2,62.2,,,58.8,65.6,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62,62,,,58.5,65.4,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.1,51.1,,,36.3,65.8,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.6,54.6,,,41.2,67.4,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.9,50.9,,,37.9,63.7,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.1,50.1,,,37.9,62.4,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,48.9,48.9,,,32.3,65.8,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.3,52.3,,,37.8,66.5,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,61.6,67.2,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.3,64.3,,,61.5,67,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.9,59.9,,,55.4,64.2,Gender,Male,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60,60,,,55.9,64,Gender,Male,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69,69,,,65.5,72.4,Gender,Female,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69,69,,,65.4,72.3,Gender,Female,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.3,65.3,,,62.4,68.1,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.1,65.1,,,62.2,67.9,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,49.2,71.4,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.4,60.4,,,48.7,71,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.2,62.2,,,59.7,64.7,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.3,61.3,,,58.8,63.8,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.4,61.4,,,57.3,65.3,Gender,Male,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.8,60.8,,,56.7,64.8,Gender,Male,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63,63,,,59.8,66,Gender,Female,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.7,61.7,,,58.6,64.7,Gender,Female,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62,62,,,59.3,64.6,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.7,60.7,,,58,63.4,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,54.1,70.3,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.7,63.7,,,56.3,70.5,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.5,58.5,,,56.4,60.6,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.4,58.4,,,56.3,60.4,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.6,57.6,,,54.4,60.7,Gender,Male,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.7,57.7,,,54.5,60.7,Gender,Male,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.4,59.4,,,56.5,62.1,Gender,Female,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,56.5,61.9,Gender,Female,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.3,64.3,,,61.9,66.7,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.4,63.4,,,60.9,65.7,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.9,70.9,,,63.7,77.2,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.9,71.9,,,65.1,77.9,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,40.5,40.5,,,36.2,45,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,43.5,43.5,,,39.5,47.5,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,45.2,45.2,,,31.4,59.8,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,40.8,40.8,,,28.4,54.4,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.9,66.9,,,47.9,81.6,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.2,68.2,,,53.9,79.7,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,*,50 States + DC: US Median,62.3,65.1,Overall,Overall,,59,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,*,50 States + DC: US Median,61.3,64.3,Overall,Overall,,59,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.3,62.3,*,50 States + DC: US Median,60.3,63.4,Gender,Male,,59,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.1,61.1,*,50 States + DC: US Median,59.9,63.2,Gender,Male,,59,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,*,50 States + DC: US Median,63,67.3,Gender,Female,,59,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,*,50 States + DC: US Median,62.1,66.3,Gender,Female,,59,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.3,68.3,,,66.8,69.8,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68,68,,,66.5,69.4,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.4,68.4,,,66.3,70.6,Gender,Male,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.2,68.2,,,66.1,70.3,Gender,Male,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.3,68.3,,,66.2,70.3,Gender,Female,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.8,67.8,,,65.7,69.8,Gender,Female,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.7,70.7,,,69.2,72.2,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,68.8,71.7,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.8,47.8,,,40.3,55.3,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,47.4,47.4,,,40.4,54.6,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.5,47.5,,,37.1,58.2,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51,51,,,40.6,61.3,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.9,66.9,,,65.2,68.7,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.6,66.6,,,64.8,68.3,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.4,64.4,,,61.6,67.1,Gender,Male,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,61.2,66.8,Gender,Male,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.2,69.2,,,67,71.4,Gender,Female,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.8,68.8,,,66.6,71,Gender,Female,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.8,67.8,,,65.8,69.7,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.2,67.2,,,65.2,69.1,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.7,64.7,,,59.8,69.3,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.6,65.6,,,60.8,70,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.7,60.7,,,47.2,72.8,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.4,63.4,,,51,74.3,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,55.6,77,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,52.2,74.2,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.3,65.3,,,49.1,78.6,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.2,64.2,,,48.7,77.2,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Gender,Male,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Gender,Female,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,66.2,69.9,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,65.1,68.8,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68,68,,,65.2,70.7,Gender,Male,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.2,67.2,,,64.3,69.9,Gender,Male,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,65.6,70.5,Gender,Female,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.8,66.8,,,64.3,69.3,Gender,Female,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.2,68.2,,,66.3,70,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,65.1,68.9,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.6,68.6,,,56.8,78.4,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,46.1,76.4,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.1,63.1,,,47.7,76.2,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,65.4,68.9,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.4,66.4,,,64.6,68.1,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.1,66.1,,,63.3,68.7,Gender,Male,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.6,65.6,,,62.8,68.2,Gender,Male,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.3,68.3,,,66,70.4,Gender,Female,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.1,67.1,,,64.8,69.3,Gender,Female,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.3,69.3,,,67.5,71,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.3,68.3,,,66.4,70,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,54.5,79.2,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.7,66.7,,,53.5,77.7,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,44,44,,,33.9,54.6,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.6,46.6,,,36.4,57.1,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.9,55.9,,,47.6,63.8,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,48.2,63.4,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.9,71.9,,,58.7,82.2,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.7,71.7,,,69.6,73.7,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.3,71.3,,,69.2,73.3,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.5,70.5,,,67.4,73.5,Gender,Male,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70,70,,,66.9,73,Gender,Male,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.8,72.8,,,70,75.5,Gender,Female,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.4,72.4,,,69.5,75.2,Gender,Female,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72,72,,,69.9,74.1,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.4,71.4,,,69.2,73.4,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,85.8,85.8,,,72.4,93.3,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,84.6,84.6,,,72.1,92.1,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.9,51.9,,,35.1,68.3,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.7,52.7,,,36.1,68.8,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.6,64.5,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61,61,,,59,62.9,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,59.7,65.6,Gender,Male,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.8,60.8,,,57.9,63.7,Gender,Male,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,59.9,65,Gender,Female,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.3,61.3,,,58.6,63.9,Gender,Female,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.1,63.1,,,61.1,65.1,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,59.5,63.5,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.9,54.9,,,41.1,68,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.7,55.7,,,42.5,68.2,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.4,54.4,,,52,56.8,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.9,53.9,,,51.5,56.2,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50,50,,,46.2,53.7,Gender,Male,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,49.6,49.6,,,46.1,53.2,Gender,Male,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59,59,,,56.1,61.8,Gender,Female,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.3,58.3,,,55.5,61.2,Gender,Female,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.9,54.9,,,52.4,57.4,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.4,54.4,,,52,56.7,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.8,47.8,,,34.3,61.6,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,47,47,,,34.8,59.6,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53.1,53.1,,,36.5,69.1,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.6,55.6,,,41.7,68.7,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
